Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma (SYSTHER)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2009 by Blood Transfusion Centre of Slovenia.
Recruitment status was  Recruiting
Information provided by:
Blood Transfusion Centre of Slovenia Identifier:
First received: November 27, 2009
Last updated: January 12, 2010
Last verified: November 2009
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)